2,4-thiazolidinedione has been researched along with Kidney Failure, Chronic in 4 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Over a 20-year period, patients on dapagliflozin were projected to experience relative reductions in the incidence of myocardial infarction (MI), stroke, CV death, and all-cause death of 13." | 3.80 | Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes. ( Alperin, P; Cohen, M; Dziuba, J; Goswami, D; Grossman, HL; Hardy, E; Iloeje, U; Perlstein, I; Racketa, J, 2014) |
| "In patients with type 2 diabetes, early use of TZDs may be beneficial in both achieving glucose control and reducing the development or worsening of microalbuminuria or hypertension." | 2.42 | Hypertension and nephropathy. ( Bakris, GL, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dziuba, J | 1 |
| Alperin, P | 1 |
| Racketa, J | 1 |
| Iloeje, U | 1 |
| Goswami, D | 1 |
| Hardy, E | 1 |
| Perlstein, I | 1 |
| Grossman, HL | 1 |
| Cohen, M | 1 |
| Kermani, A | 1 |
| Garg, A | 1 |
| Bakris, GL | 1 |
| Nishimura, F | 1 |
| Iwamoto, Y | 1 |
| Soga, Y | 1 |
2 reviews available for 2,4-thiazolidinedione and Kidney Failure, Chronic
| Article | Year |
|---|---|
Hypertension and nephropathy.
Topics: Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension, Renovascula | 2003 |
The periodontal host response with diabetes.
Topics: Animals; Atherosclerosis; Diabetes Complications; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA R | 2007 |
2 other studies available for 2,4-thiazolidinedione and Kidney Failure, Chronic
| Article | Year |
|---|---|
Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes.
Topics: Amputation, Surgical; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Cardiovascul | 2014 |
Thiazolidinedione-associated congestive heart failure and pulmonary edema.
Topics: Aged; Cardiomyopathies; Diabetes Mellitus, Type 2; Heart Failure; Humans; Hypoglycemic Agents; Kidne | 2003 |